{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid7gkmvuzqkjtaihvvu7el5bar6bucznmp7uajpvdhy4eytwn5exa",
    "uri": "at://did:plc:q27hltg3oatmy4g7oio4vbc3/app.bsky.feed.post/3mleh6vvfsuh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifipo4sw37gnki66sapb4pd4kh3xtpfkuavogpqg3m7bsbmpwvr3y"
    },
    "mimeType": "image/jpeg",
    "size": 45086
  },
  "path": "/health/some-gene-therapies-no-longer-require-clinical-trials-thanks-to-new-fda-rule-is-this-safe-and-who-will-it-help",
  "publishedAt": "2026-05-08T16:45:50.000Z",
  "site": "https://www.livescience.com",
  "tags": [
    "Health"
  ],
  "textContent": "The FDA is launching a new framework to deliver tailor-made gene therapies to people with rare genetic disorders. Discussions about whom to treat and how to monitor patients are ongoing.",
  "title": "Some gene therapies no longer require clinical trials, thanks to new FDA rule. Is this safe, and who will it help?"
}